#TeamCastle celebrates #EyePatchDays 5/17-19, spotlighting #UvealMelanoma (aka #OcularMelanoma ), with a little bling, a 'feast your eyes' bake-off & more cake this year (carrot cake, of course, for eye health).

#MelanomaAwarenessMonth ☀️ #SkinCancerAwarenessMonth 🌞

It's #WorldBarrettsEsophagusDay .

'Chronic reflux over time can lead to a change in the lining of the esophagus...that new tissue—that tougher lining termed Barrett's esophagus—is now much more prone to the development of cancer.' John C. Lipham, MD: hubs.ly/Q02x713R0

This month: Castle's executive management will present a company overview at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29th at 2:00pm ET.

Details/register for live audio webcast: hubs.la/Q02xfvy_0

The Miles for Melanoma DC 5K was a great success! #TeamCastle was proud to support the Melanoma Research Foundation Melanoma Research Foundation this past weekend, helping to raise more than $100,000 towards eradicating melanoma.

This week, Castle will share 3 abstracts supporting the ability of its #TissueCypher ® test to predict risk of progression to esophageal cancer in patients with Barrett’s esophagus (BE) at the #DDW2024 Annual Meeting, 5/18-21 in Washington, D.C.

Details: hubs.la/Q02x4FCC0

Castle is honored to have won the 'Best Overall Mental Health Solution' award in the 8th annual MedTech Breakthrough Awards program for our IDgenetix® pharmacogenomic (PGx) test. More: hubs.la/Q02wPdFs0

Studies have shown that long BE segments carry a greater *population-based* cancer risk than short segments. Unfortunately, many short-segment patients still end up progressing because they have a higher *personal risk* of progression. Check out the study: hubs.la/Q02wH1dF0

#FollowTheLeader w/ Frank Stokes

Hear from $CSTL CFO Frank Stokes on finance & banking as a career.

#FunFact : Frank was recently recognized as one of the Top 25 Houston CFOs for the 2nd consecutive year & was featured as one of the most impactful CFOs to watch in 2024.

NEW DATA: Oral presentation at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting shares ground-breaking findings from the ongoing Collaborative Ocular Oncology Group (COOG) study 2 (COOG2) of patients with uveal melanoma. hubs.la/Q02wBYBz0

It was a great weekend for practicing sun safety!

The Sun Bus visit at last weekend's NASCAR event in Kansas City was a huge success, conducting dozens of free skin checks (and of course, providing the sunscreen!) and educating race goers about safe skin practices. thesunbus

#TeamCastle was proud to be a National Grassroots Sponsor this past weekend of the Melanoma Research Foundation's 2024 New England Miles for Melanoma 5K, helping them reach 153% of their $90,000 goal toward #melanoma research, education, and advocacy! Melanoma Research Foundation

THIS WEEK: Data regarding the DecisionDx®-UM test will be presented at the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting via a poster presentation detailing the findings from the ongoing COOG2 study of patients with uveal melanoma. #ARVO2024

NEW DATA supporting the utility of Castle's DecisionDx®-SCC test in patients with high-risk cutaneous squamous cell carcinoma tumors located on the head & neck will be shared at the 56th American College of Mohs Surgery (ACMS) Annual Meeting 5/2-5. More: hubs.ly/Q02w2K-20

⏰SET YOUR ALARM⏰

You won't want to miss the latest episode of The Balancing Act showcasing DecisionDx-SCC and DecisionDx-Melanoma. Tune in this Monday, May 6th at 7:30 AM EST and 7:30 AM PST to catch the on Lifetime.

JUST RELEASED: $CSTL Q1 2024 #earnings

Q1 2024 Highlights: Revenue up 74% over Q1-23 to $73M; delivered 20,888 total test reports, up 40% over Q1-23; raising full-year 2024 revenue guidance to $255-265M from $235-240M, as of 3/31/24

Details/webcast: hubs.la/Q02vZ91w0

Friendswood joins county in raising awareness to prevent skin cancer. $CSTL kicks off #SkinCancerAwarenessMonth w/ ribbon cutting honoring Friendswood as Sun Safe Leadership Model City by IMPACT Melanoma.
galvnews.com/news/friendswo… via The Daily News

JOIN US TODAY: $CSTL will release Q1 2024 financial results via a conference call and webcast at 4:30 pm ET. Registration/log-in details here: hubs.la/Q02vRJVC0

#TeamCastle was proud to team up with IMPACT Melanoma (official sunscreen sponsor) this past weekend for the 40th annual Bike MS: Bike MS: Texas MS 150, keeping safe skin in the spotlight for every mile!

#PracticeSafeSkin #TexasMS150 #SkinCancerAwareness

May is #SkinCancerAwarenessMonth and we're kicking it off with a ribbon cutting this Friday to celebrate the City of Friendswood's designation as a Sun Safe Leadership Model City by IMPACT Melanoma! Details about this & other sun-safe initiatives: hubs.la/Q02vHTWL0

We're excited to kick off #SkinCancerAwarenessMonth this week, beginning with Friday's ribbon cutting recognizing Friendswood as a Sun Safe Leadership Model City by IMPACT Melanoma, followed by additional initiatives... Details: hubs.la/Q02vCJZM0 #CastleCares